SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-13 |
| Reported value | $645,523,811 |
| Positions | 23 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| ROIVANT SCIENCES LTD | ROIV | SHS | $283,860,642 | 8,020,928 |
| REVOLUTION MEDICINES INC | RVMD | COM | $51,689,280 | 276,000 |
| MIRUM PHARMACEUTICALS INC | MIRM | COM | $30,496,735 | 260,500 |
| ABIVAX SA | ABVX | SPONSORED ADS | $27,518,190 | 206,500 |
| BEONE MEDICINES LTD | ONC | SPONSORED ADS | $25,652,999 | 90,020 |
| PHARVARIS N V | PHVS | COM | $23,210,407 | 671,209 |
| ARGENX SE | ARGX | SPONSORED ADR | $21,338,710 | 23,000 |
| UNITED THERAPEUTICS CORP DEL | UTHR | COM | $20,112,730 | 37,120 |
| BELITE BIO INC | BLTE | SPONSORED ADS | $16,938,350 | 110,000 |
| COGENT BIOSCIENCES INC | COGT | COM | $16,447,500 | 425,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.